These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

154 related items for PubMed ID: 25589849

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Clinical analysis of 56 patients with rhupus syndrome: manifestations and comparisons with systemic lupus erythematosus: a retrospective case-control study.
    Li J, Wu H, Huang X, Xu D, Zheng W, Zhao Y, Liu W, Zeng X.
    Medicine (Baltimore); 2014 Aug; 93(10):e49. PubMed ID: 25170930
    [Abstract] [Full Text] [Related]

  • 4. Successful treatment using cyclosporine in a patient with rhupus complicated by aplastic anemia: a case report and review of the literature.
    Seo SR, Lee SJ, Park DJ, Kim TJ, Park YW, Lee SS.
    Clin Exp Rheumatol; 2011 Aug; 29(4):708-11. PubMed ID: 21813067
    [Abstract] [Full Text] [Related]

  • 5. Peculiar myelopathy in a patient with overlap syndrome with lupus- and rheumatoid-like symptoms.
    Tsai CY, Tsai YY, Tsai ST, Wu TH, Yu CL, Chou CT.
    Clin Exp Rheumatol; 2000 Aug; 18(2):272-3. PubMed ID: 10812515
    [No Abstract] [Full Text] [Related]

  • 6. Belimumab treatment in rhupus: A case report with severe skin involvement.
    Castillo Dayer PV, Lozano Rivas N, Martínez Ferrín JJ, Victoria Martínez AM, Sánchez-Pedreño Guillen P, Marras Fernández-Cid C.
    Dermatol Ther; 2019 Sep; 32(5):e13056. PubMed ID: 31393634
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Rituximab treatment for 'rhupus syndrome': clinical and power-Doppler ultrasonographic monitoring of response. A longitudinal pilot study.
    Piga M, Gabba A, Cauli A, Garau P, Vacca A, Mathieu A.
    Lupus; 2013 May; 22(6):624-8. PubMed ID: 23559669
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Mortality due to sepsis in patients with systemic lupus erythematosus and rheumatoid arthritis.
    Barrett O, Abramovich E, Dreiher J, Novack V, Abu-Shakra M.
    Isr Med Assoc J; 2014 Oct; 16(10):634-5. PubMed ID: 25438453
    [No Abstract] [Full Text] [Related]

  • 16. Rituximab treatment in a child with rosai-dorfman disease and systemic lupus erythematosus.
    Alqanatish JT, Houghton K, Bond M, Senger C, Tucker LB.
    J Rheumatol; 2010 Aug 01; 37(8):1783-4. PubMed ID: 20675857
    [No Abstract] [Full Text] [Related]

  • 17. Renal manifestations of rheumatological disorders.
    Biswas S, Paul R.
    J Indian Med Assoc; 2013 Aug 01; 111(8):542-4, 552. PubMed ID: 24783393
    [No Abstract] [Full Text] [Related]

  • 18. [Indications for the so-called immunosuppressive therapy. With special reference to the diffuse connective tissue diseases].
    Messini M, Guglielmi G, Ciavarelli F, Messini R.
    Clin Ter; 1969 Jan 31; 48(2):105-44. PubMed ID: 5404642
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.